Calidi Biotherapeutics
CLDI
CLDI
30 hedge funds and large institutions have $1.53M invested in Calidi Biotherapeutics in 2024 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
46% less capital invested
Capital invested by funds: $2.85M → $1.53M (-$1.32M)
Holders
30
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$332K | |
| 2 | +$70.6K | |
| 3 | +$44.8K | |
| 4 |
EWM
Evermay Wealth Management
Arlington,
Virginia
|
+$35.8K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$35.3K |
Top Sellers
| 1 | -$154K | |
| 2 | -$37.4K | |
| 3 | -$26K | |
| 4 |
MC
Meteora Capital
Boca Raton,
Florida
|
-$22K |
| 5 |
AWM
Axxcess Wealth Management
Carlsbad,
California
|
-$19.9K |